IL75120A - 2-substituted-6-,7-dihydro-3h,5h-pyrrolo(2,3-f)benzimidazole-6-(thi)ones,processes for the preparation thereof and pharmaceutical compositions containing them - Google Patents
2-substituted-6-,7-dihydro-3h,5h-pyrrolo(2,3-f)benzimidazole-6-(thi)ones,processes for the preparation thereof and pharmaceutical compositions containing themInfo
- Publication number
- IL75120A IL75120A IL75120A IL7512085A IL75120A IL 75120 A IL75120 A IL 75120A IL 75120 A IL75120 A IL 75120A IL 7512085 A IL7512085 A IL 7512085A IL 75120 A IL75120 A IL 75120A
- Authority
- IL
- Israel
- Prior art keywords
- thi
- pyrrolo
- benzimidazole
- dihydro
- ones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/96—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL84769A IL84769A (en) | 1984-05-12 | 1985-05-07 | Substituted indolin-2-(thi)ones |
IL84769A IL84769A0 (en) | 1984-05-12 | 1987-12-09 | Substituted indolin-2-(thi)ones |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843417643 DE3417643A1 (de) | 1984-05-12 | 1984-05-12 | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
DE19843446417 DE3446417A1 (de) | 1984-12-20 | 1984-12-20 | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
Publications (2)
Publication Number | Publication Date |
---|---|
IL75120A0 IL75120A0 (en) | 1985-09-29 |
IL75120A true IL75120A (en) | 1989-02-28 |
Family
ID=25821132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL75120A IL75120A (en) | 1984-05-12 | 1985-05-07 | 2-substituted-6-,7-dihydro-3h,5h-pyrrolo(2,3-f)benzimidazole-6-(thi)ones,processes for the preparation thereof and pharmaceutical compositions containing them |
Country Status (18)
Country | Link |
---|---|
US (2) | US4666923A (ja) |
EP (1) | EP0161632B1 (ja) |
JP (2) | JPH0647593B2 (ja) |
KR (1) | KR870001201B1 (ja) |
AU (1) | AU560349B2 (ja) |
DE (1) | DE3582447D1 (ja) |
DK (1) | DK209585A (ja) |
ES (1) | ES542976A0 (ja) |
FI (1) | FI81351C (ja) |
GR (1) | GR851085B (ja) |
HU (1) | HU193754B (ja) |
IL (1) | IL75120A (ja) |
NO (1) | NO851862L (ja) |
NZ (1) | NZ212005A (ja) |
PH (1) | PH22863A (ja) |
PL (2) | PL147842B1 (ja) |
PT (1) | PT80425B (ja) |
SU (1) | SU1480770A3 (ja) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL147842B1 (en) * | 1984-05-12 | 1989-08-31 | Method of obtaining novel pyroisobenzimidazoles | |
DE3445669A1 (de) * | 1984-12-14 | 1986-06-19 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3501497A1 (de) * | 1985-01-18 | 1986-07-24 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
DE3524067A1 (de) * | 1985-07-05 | 1987-01-08 | Boehringer Mannheim Gmbh | Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
DE3530825A1 (de) * | 1985-08-29 | 1987-03-05 | Boehringer Mannheim Gmbh | Neue benzodipyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3531678A1 (de) * | 1985-09-05 | 1987-03-12 | Boehringer Mannheim Gmbh | Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3626664A1 (de) * | 1986-08-07 | 1988-02-11 | Boehringer Mannheim Gmbh | Tricyclische benzotriazole, verfahren zu ihrer herstellung sowie arzneimittel |
DE3639466A1 (de) * | 1986-11-18 | 1988-05-19 | Thomae Gmbh Dr K | Neue pyrrolo-benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE3642315A1 (de) * | 1986-12-11 | 1988-06-23 | Boehringer Mannheim Gmbh | Neue pyrrolobenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel |
DE3740985A1 (de) * | 1987-12-03 | 1989-06-15 | Boehringer Mannheim Gmbh | Verwendung linear anellierter tricyclen als hemmer der erythrozytenaggregation |
US4963677A (en) * | 1987-12-30 | 1990-10-16 | Orion Corporation Ltd. | Heterocyclic lactam compounds |
DE3855327D1 (de) * | 1987-12-30 | 1996-07-04 | Orion Yhtymae Oy | Heterocyclische Verbindungen |
DE3803775A1 (de) * | 1988-02-09 | 1989-08-17 | Boehringer Mannheim Gmbh | Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
US5324911A (en) * | 1990-01-08 | 1994-06-28 | Schroer Manufacturing Company | Heated animal surgery table |
DE4027592A1 (de) * | 1990-08-31 | 1992-03-05 | Beiersdorf Ag | Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
US20060142247A1 (en) * | 2004-12-17 | 2006-06-29 | Guy Georges | Tricyclic heterocycles |
CN101160312A (zh) * | 2005-04-14 | 2008-04-09 | 霍夫曼-拉罗奇有限公司 | 三环吡咯衍生物、它们的制备和作为药剂的应用 |
WO2006108489A1 (en) * | 2005-04-14 | 2006-10-19 | F. Hoffmann-La Roche Ag | Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents |
AU2006326247A1 (en) * | 2005-12-15 | 2007-06-21 | F. Hoffmann-La Roche Ag | Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
CN101400681A (zh) * | 2006-03-23 | 2009-04-01 | 霍夫曼-拉罗奇有限公司 | 取代的吲唑衍生物,它们的制备和作为药剂的应用 |
US8063225B2 (en) * | 2006-08-14 | 2011-11-22 | Chembridge Corporation | Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders |
MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
RU2443704C1 (ru) * | 2010-10-29 | 2012-02-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" | СУЛЬФАТЫ 2-АРИЛ-4-ДИАЛКИЛАМИНОЭТИЛ-3-ФЕНИЛПИРРОЛО[1,2-a]-БЕНЗИМИДАЗОЛОВ, ОБЛАДАЮЩИЕ АНТИОКСИДАНТНЫМИ И АНТИРАДИКАЛЬНЫМИ СВОЙСТВАМИ |
US9580471B2 (en) | 2011-03-01 | 2017-02-28 | Synergy Pharmaceuticals, Inc. | Process of preparing guanylate cyclase C agonists |
JP6116693B2 (ja) | 2012-09-13 | 2017-04-19 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Cns障害の処置のための2−オキソ−2,3−ジヒドロ−インドール |
US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法 |
JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス,インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
GB201709456D0 (en) * | 2017-06-14 | 2017-07-26 | Ucb Biopharma Sprl | Therapeutic agents |
WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
JP6854953B1 (ja) | 2020-06-16 | 2021-04-07 | 株式会社ソディック | ワイヤ放電加工装置 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1158532A (en) * | 1967-01-05 | 1969-07-16 | Centre Nat Rech Scient | 2-Oxoindoline-3-Carboxylic Acids and Esters thereof |
BE714717A (ja) * | 1967-05-12 | 1968-09-30 | ||
FR1529901A (fr) * | 1967-05-12 | 1968-06-21 | Centre Nat Rech Scient | Procédé de préparation de lactames se rattachant à l'indolinone et à l'oxo quinoléine |
US4322533A (en) * | 1980-03-17 | 1982-03-30 | Lesher George Y | 1H-Indole-2,3-dione derivatives |
CH644116A5 (de) * | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
DE3224512A1 (de) * | 1982-07-01 | 1984-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel |
PL147842B1 (en) * | 1984-05-12 | 1989-08-31 | Method of obtaining novel pyroisobenzimidazoles |
-
1985
- 1985-05-06 PL PL1985259261A patent/PL147842B1/pl unknown
- 1985-05-06 PL PL1985253246A patent/PL144822B1/pl unknown
- 1985-05-06 GR GR851085A patent/GR851085B/el unknown
- 1985-05-07 IL IL75120A patent/IL75120A/xx unknown
- 1985-05-07 US US06/731,500 patent/US4666923A/en not_active Expired - Lifetime
- 1985-05-07 NZ NZ212005A patent/NZ212005A/xx unknown
- 1985-05-08 PH PH32240A patent/PH22863A/en unknown
- 1985-05-09 KR KR1019850003144A patent/KR870001201B1/ko not_active IP Right Cessation
- 1985-05-09 DE DE8585105675T patent/DE3582447D1/de not_active Expired - Lifetime
- 1985-05-09 EP EP85105675A patent/EP0161632B1/de not_active Expired - Lifetime
- 1985-05-09 AU AU42222/85A patent/AU560349B2/en not_active Ceased
- 1985-05-09 PT PT80425A patent/PT80425B/pt not_active IP Right Cessation
- 1985-05-09 ES ES542976A patent/ES542976A0/es active Granted
- 1985-05-10 HU HU851775A patent/HU193754B/hu not_active IP Right Cessation
- 1985-05-10 FI FI851869A patent/FI81351C/fi not_active Application Discontinuation
- 1985-05-10 SU SU853894709A patent/SU1480770A3/ru active
- 1985-05-10 NO NO851862A patent/NO851862L/no unknown
- 1985-05-10 DK DK209585A patent/DK209585A/da not_active Application Discontinuation
- 1985-05-13 JP JP60099742A patent/JPH0647593B2/ja not_active Expired - Lifetime
-
1988
- 1988-07-05 US US07/217,143 patent/US4963686A/en not_active Expired - Fee Related
-
1993
- 1993-12-10 JP JP5310823A patent/JPH0772185B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES8603178A1 (es) | 1986-01-01 |
JPH0741474A (ja) | 1995-02-10 |
IL75120A0 (en) | 1985-09-29 |
JPH0647593B2 (ja) | 1994-06-22 |
FI81351C (fi) | 1990-10-10 |
US4666923A (en) | 1987-05-19 |
EP0161632A2 (de) | 1985-11-21 |
AU4222285A (en) | 1985-11-14 |
AU560349B2 (en) | 1987-04-02 |
EP0161632B1 (de) | 1991-04-10 |
PT80425A (de) | 1985-06-01 |
JPH0772185B2 (ja) | 1995-08-02 |
KR850008170A (ko) | 1985-12-13 |
FI81351B (fi) | 1990-06-29 |
PT80425B (de) | 1987-04-16 |
PH22863A (en) | 1989-01-19 |
US4963686A (en) | 1990-10-16 |
GR851085B (ja) | 1985-11-25 |
PL253246A1 (en) | 1986-08-26 |
SU1480770A3 (ru) | 1989-05-15 |
EP0161632A3 (en) | 1986-06-11 |
JPS60246386A (ja) | 1985-12-06 |
FI851869L (fi) | 1985-11-13 |
DK209585A (da) | 1985-11-13 |
HU193754B (en) | 1987-11-30 |
KR870001201B1 (ko) | 1987-06-20 |
FI851869A0 (fi) | 1985-05-10 |
PL144822B1 (en) | 1988-07-30 |
DK209585D0 (da) | 1985-05-10 |
HUT37938A (en) | 1986-03-28 |
NO851862L (no) | 1985-11-13 |
ES542976A0 (es) | 1986-01-01 |
PL147842B1 (en) | 1989-08-31 |
NZ212005A (en) | 1989-07-27 |
DE3582447D1 (de) | 1991-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL75120A (en) | 2-substituted-6-,7-dihydro-3h,5h-pyrrolo(2,3-f)benzimidazole-6-(thi)ones,processes for the preparation thereof and pharmaceutical compositions containing them | |
IL75400A0 (en) | Dialkoxypyridines,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL76591A0 (en) | Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof | |
GB8613688D0 (en) | Pharmaceutical composition | |
ZA859756B (en) | Peptide-aldehydes,process for the preparation thereof and pharmaceutical compositions containing the same | |
GB8708659D0 (en) | Pharmaceutical composition | |
GB2153678B (en) | Pharmaceutical composition | |
EP0163178A3 (en) | Pharmaceutical composition | |
ZA879166B (en) | Pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them | |
EG17710A (en) | Process for the preparation isosilybin-free silbinin and pharmaceutical compositions containing them | |
GB2153677B (en) | Pharmaceutical composition | |
IL78576A0 (en) | 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same | |
GB8713632D0 (en) | Oculistics pharmaceutical composition | |
GB8628373D0 (en) | Pharmaceutical composition | |
GB8709166D0 (en) | Pharmaceutical composition | |
GB8614189D0 (en) | Pharmaceutical composition | |
ZA853375B (en) | New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them | |
GB2153676B (en) | Pharmaceutical composition | |
GB8621008D0 (en) | Pharmaceutical composition | |
GB8706824D0 (en) | Pharmaceutical composition | |
GB8722205D0 (en) | Pharmaceutical composition | |
GB8704660D0 (en) | Pharmaceutical composition | |
GB8725539D0 (en) | Pharmaceutical composition | |
ZA876263B (en) | Pharmaceutical composition | |
ZA876748B (en) | Pharmaceutical composition |